Brote nosocomial de COVID-19 en una planta de medicina interna: probable transmisión aérea / Nosocomial outbreak of COVID-19 in an internal medicine ward: Probable airborne transmission

Antecedentes y objetivos A pesar de los datos cada vez mayores que respaldan la importancia de la transmisión aérea en la infección por el SARS-CoV-2, en la inmensa mayoría de los brotes nosocomiales descritos de COVID-19 no se ha considerado relevante. El objetivo de este estudio consiste en describir un brote nosocomial de infección por el SARS-CoV-2 cuyas características indican que la transmisión por aerosoles desempeñó un papel importante. Métodos Se trata de un análisis descriptivo de un brote nosocomial de infección por el SARS-CoV-2 en una planta de medicina interna que tuvo lugar en diciembre de 2020. Todos los casos se confirmaron mediante una PCR positiva para SARS-CoV-2. Resultados Entre el 5 y el 17 de diciembre, 21 pacientes y 44 profesionales sanitarios contrajeron una infección nosocomial por el SARS-CoV-2. De los 65 casos, 51 (78,5%) se diagnosticaron entre el 6 y el 9 de diciembre. La tasa de afectación en los pacientes fue del 80,8%. Entre los profesionales sanitarios, la tasa fue mayor en los que habían trabajado al menos una jornada laboral completa en la planta (56,3%) que en los que habían estado ocasionalmente en ella (25,8%; p=0,005). Tres días antes de detectar el primer caso positivo se identificó una avería en 2extractores de aire, que afectó a la ventilación de 3habitaciones. Dieciséis casos cursaron de forma asintomática, 48 manifestaron síntomas leves y 2 precisaron ingreso en la unidad de cuidados intensivos. Todos los casos se recuperaron finalmente. Conclusiones La elevada tasa de afectación, la naturaleza explosiva del brote y la coincidencia en el tiempo con la avería de los extractores de aire en algunas habitaciones de la planta indican que la transmisión aérea desempeñó un papel fundamental en el desarrollo del brote (AU)

Background and objectives Despite the increasing evidence supporting the importance of airborne transmission in SARS-CoV-2 infection, it has not been considered relevant in the vast majority of reported nosocomial outbreaks of COVID-19. The aim of this study is to describe a nosocomial outbreak of SARS-CoV-2 infection whose features suggest that aerosol transmission had an important role. Methods This is a descriptive analysis of a nosocomial outbreak of SARS-CoV-2 infection in an internal medicine ward that occurred in December 2020. All cases were confirmed by a positive PCR test for SARS-CoV-2. Results From December 5 to December 17, 21 patients and 44 healthcare workers developed a nosocomial SARS-CoV-2 infection. Fifty-one of the 65 cases (78.5%) were diagnosed between December 6 and 9. The attack rate in patients was 80.8%. Among workers, the attack rate was higher in those who had worked at least one full working day in the ward (56.3%) than in those who had occasionally been in the ward (25.8%, p=0.005). Three days before the first positive case was detected, 2extractor fans were found to be defective, affecting the ventilation of 3rooms. Sixteen cases were asymptomatic, 48 cases had non-severe symptoms, and 2 cases required admission to the intensive care unit. All patients eventually recovered. Conclusion The high attack rate, the explosive nature of the outbreak, and the coincidence in time with the breakdown in air extractors in some rooms of the ward suggest that airborne transmission played a key role in the development of the outbreak (AU)

Nosocomial outbreak of COVID-19 in an internal medicine ward: Probable airborne transmission.

BACKGROUND AND OBJECTIVES: Despite the increasing evidence supporting the importance of airborne transmission in SARS-CoV-2 infection, it has not been considered relevant in the vast majority of reported nosocomial outbreaks of COVID-19. The aim of this study is to describe a nosocomial outbreak of SARS-CoV-2 infection whose features suggest that aerosol transmission had an important role. METHODS: This is a descriptive analysis of a nosocomial outbreak of SARS-CoV-2 infection in an internal medicine ward that occurred in December 2020. All cases were confirmed by a positive PCR test for SARS-CoV-2. RESULTS: From December 5 to December 17, 21 patients and 44 healthcare workers (HCWs) developed a nosocomial SARS-CoV-2 infection. Fifty-one of the 65 cases (78.5%) were diagnosed between December 6 and 9. The attack rate in patients was 80.8%. Among HCWs, the attack rate was higher in those who had worked at least one full working day in the ward (56.3%) than in those who had occasionally been in the ward (25.8%; p = 0.005). Three days before the first positive case was detected, two extractor fans were found to be defective, affecting the ventilation of three rooms. Sixteen cases were asymptomatic, 48 cases had non-severe symptoms, and 2 cases required admission to the intensive care unit. All patients eventually recovered. CONCLUSION: The high attack rate, the explosive nature of the outbreak, and the coincidence in time with the breakdown in air extractors in some rooms of the ward suggest that airborne transmission played a key role in the development of the outbreak.

[Nosocomial outbreak of COVID-19 in an internal medicine ward: Probable airborne transmission]. / Brote nosocomial de COVID-19 en una planta de medicina interna: probable transmisión aérea.

Background and objectives: Despite the increasing evidence supporting the importance of airborne transmission in SARS-CoV-2 infection, it has not been considered relevant in the vast majority of reported nosocomial outbreaks of COVID-19. The aim of this study is to describe a nosocomial outbreak of SARS-CoV-2 infection whose features suggest that aerosol transmission had an important role. Methods: This is a descriptive analysis of a nosocomial outbreak of SARS-CoV-2 infection in an internal medicine ward that occurred in December 2020. All cases were confirmed by a positive PCR test for SARS-CoV-2. Results: From December 5 to December 17, 21 patients and 44 healthcare workers developed a nosocomial SARS-CoV-2 infection. Fifty-one of the 65 cases (78.5%) were diagnosed between December 6 and 9. The attack rate in patients was 80.8%. Among workers, the attack rate was higher in those who had worked at least one full working day in the ward (56.3%) than in those who had occasionally been in the ward (25.8%, p = 0.005). Three days before the first positive case was detected, 2 extractor fans were found to be defective, affecting the ventilation of 3 rooms. Sixteen cases were asymptomatic, 48 cases had non-severe symptoms, and 2 cases required admission to the intensive care unit. All patients eventually recovered. Conclusion: The high attack rate, the explosive nature of the outbreak, and the coincidence in time with the breakdown in air extractors in some rooms of the ward suggest that airborne transmission played a key role in the development of the outbreak.

Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.

Six cases of patients diagnosed with urinary tract infection (UTI) successfully treated with micafungin are reported. Four were infected with fluconazole-resistant Candida spp. and two (with hepatic injury) were infected with fluconazole-sensitive Candida spp. Traditionally, echinocandins have not been considered for the treatment of UTIs. However, despite its low urinary excretion rate, therapeutic drug monitoring of micafungin urinary levels could be helpful in order to achieve optimal pharmacokinetic/pharmacodynamic (PK/PD) indices for treating UTIs caused by Candida spp. resistant to fluconazole.

Optimización de los aislamientos preventivos en una UCI polivalente mediante la aplicación de un plan de intervención / Optimization of pre-emptive isolations in a polyvalent ICU through implementation of an intervention strategy

ANTECEDENTES: El aislamiento preventivo consiste en la aplicación de medidas de aislamiento de contacto en pacientes con alta sospecha de estar colonizados por bacterias multirresistentes. OBJETIVO: Evaluar el impacto de un programa de intervención basado en la implantación de un Protocolo Consensuado de Aislamiento Preventivo (PCAP) al ingreso en una UCI polivalente de un hospital general. MÉTODO: Análisis comparativo de 2 cohortes de pacientes, una histórica, que incluye pacientes a los que se indicó el aislamiento preventivo a juicio del médico responsable (enero de 2010 a febrero de 2011), y otra prospectiva, que incluye los pacientes a los que se aplicó el PCAP (marzo a noviembre de 2011). El PCAP incluyó la identificación y divulgación de los criterios de aislamiento preventivo, la metodología a seguir en cuanto a toma de muestras, la valoración de los resultados y los criterios de retirada del aislamiento. La indicación del aislamiento fue realizada por el personal médico, y un equipo de enfermería realizó el seguimiento. Se definió el aislamiento preventivo como «adecuado» cuando en alguna de las muestras iniciales se identificó una bacteria multirresistente. Para la comparación de resultados entre los 2 periodos se utiliza la chi cuadrado para variables cualitativas y la t de Student para variables cuantitativas. Se aceptan como significativas diferencias con p < 0,05. RESULTADOS: De los 1.740 pacientes ingresados en UCI (1.055 en el primer periodo y 685 en el segundo) se indicó el aislamiento preventivo en 199 (11,4%), de los que 111 (10,5%) correspondieron a la fase histórica (grupo control) y 88 (12,8%) a la fase posterior a la implantación del PCAP (grupo de intervención). No se han detectado diferencias en la edad, el APACHE II y las características de los pacientes entre los 2 periodos. La aplicación del PCAP se ha relacionado con una disminución de los aislamientos preventivos no indicados (29,7 vs. 6,8%, p < 0,001), una disminución del tiempo en la solicitud de las muestras de vigilancia (1,56 vs. 0,37 días, p < 0,001), y una disminución de la duración en días del aislamiento (4,77 vs. 3,58 días, p < 0,001). En 44 pacientes (22,1%) en los que se indicó el aislamiento preventivo se identificaron más de una bacteria multirresistente, siendo la tasa de «aislamiento preventivo adecuado» del 19,8% en el primer periodo y del 25,0% en el segundo (p < 0,382). CONCLUSIONES: Tras la instauración de PCAP se han reducido significativamente los aislamientos preventivos no indicados correctamente, se ha disminuido el tiempo entre el aislamiento y la toma de muestras, además de reducirse la duración del aislamiento en los casos en que no es necesario, sin que haya aumentado la tasa de «aislamiento preventivo adecuado»

BACKGROUND: Pre-emptive isolation refers to the application of contact precaution measures in patients with strongly suspected colonization by multiresistant bacteria. OBJECTIVE: To assess the impact of an intervention program involving the implementation of a consensus-based protocol of pre-emptive isolation (CPPI) on admission to a polyvalent ICU of a general hospital. METHODS: A comparative analysis of 2 patient cohorts was made: a historical cohort including patients in which pre-emptive isolation was established according to physician criterion prior to starting CPPI (from January 2010 to February 2011), and a prospective cohort including patients in which CPPI was implemented (from March to November 2011). CPPI included the identification and diffusion of pre-emptive isolation criteria, the definition of sampling methodology, the evaluation of results, and the development of criteria for discontinuation of pre-emptive isolation. Pre-emptive isolation was indicated by the medical staff, and follow-up was conducted by the nursing staff. Pre-emptive isolation was defined as "adequate" when at least one multiresistant bacteria was identified in any of the samples. Comparison of data between the 2 periods was made with the chi-square test for categorical variables and the Student t-test for quantitative variables. Statistical significance was set at P < .05. RESULTS: Among the 1,740 patients admitted to the ICU (1,055 during the first period and 685 during the second period), pre-emptive isolation was indicated in 199 (11.4%); 111 (10.5%) of these subjects corresponded to the historical cohort (control group) and 88 (12.8%) to the posterior phase after the implementation of CPPI (intervention group). No differences were found in age, APACHE II score or patient characteristics between the 2 periods. The implementation of CPPI was related to decreases in non-indicated pre-emptive isolations (29.7 vs. 6.8%, P<.001), time of requesting surveillance cultures (1.56 vs. 0.37 days, P<.001), and days of duration of treatment (4.77 vs. 3.58 days, P<.001). In 44 patients (22.1%) in which pre-emptive isolation was indicated, more than one multiresistant bacteria was identified, with an "adequate pre-emptive isolation rate” of 19.8% in the first period and 25.0% in the second period (P<.382). CONCLUSIONS: The implementation of CPPI resulted in a significant decrease in pre-emptive isolations which were not indicated correctly, a decrease in the time elapsed between isolation and collection of samples, and a decrease in the duration of isolation measures in cases in which isolation was unnecessary, without increasing the rate of "adequate pre-emptive isolation"

Optimization of pre-emptive isolations in a polyvalent ICU through implementation of an intervention strategy.

BACKGROUND: Pre-emptive isolation refers to the application of contact precaution measures in patients with strongly suspected colonization by multiresistant bacteria. OBJECTIVE: To assess the impact of an intervention program involving the implementation of a consensus-based protocol of pre-emptive isolation (CPPI) on admission to a polyvalent ICU of a general hospital. METHODS: A comparative analysis of 2 patient cohorts was made: a historical cohort including patients in which pre-emptive isolation was established according to physician criterion prior to starting CPPI (from January 2010 to February 2011), and a prospective cohort including patients in which CPPI was implemented (from March to November 2011). CPPI included the identification and diffusion of pre-emptive isolation criteria, the definition of sampling methodology, the evaluation of results, and the development of criteria for discontinuation of pre-emptive isolation. Pre-emptive isolation was indicated by the medical staff, and follow-up was conducted by the nursing staff. Pre-emptive isolation was defined as "adequate" when at least one multiresistant bacteria was identified in any of the samples. Comparison of data between the 2 periods was made with the chi-square test for categorical variables and the Student t-test for quantitative variables. Statistical significance was set at P<.05. RESULTS: Among the 1,740 patients admitted to the ICU (1,055 during the first period and 685 during the second period), pre-emptive isolation was indicated in 199 (11.4%); 111 (10.5%) of these subjects corresponded to the historical cohort (control group) and 88 (12.8%) to the posterior phase after the implementation of CPPI (intervention group). No differences were found in age, APACHE II score or patient characteristics between the 2 periods. The implementation of CPPI was related to decreases in non-indicated pre-emptive isolations (29.7 vs. 6.8%, P<.001), time of requesting surveillance cultures (1.56 vs. 0.37 days, P<.001), and days of duration of treatment (4.77 vs. 3.58 days, P<.001). In 44 patients (22.1%) in which pre-emptive isolation was indicated, more than one multiresistant bacteria was identified, with an "adequate pre-emptive isolation rate" of 19.8% in the first period and 25.0% in the second period (P<.382). CONCLUSIONS: The implementation of CPPI resulted in a significant decrease in pre-emptive isolations which were not indicated correctly, a decrease in the time elapsed between isolation and collection of samples, and a decrease in the duration of isolation measures in cases in which isolation was unnecessary, without increasing the rate of "adequate pre-emptive isolation".

Significado clínico del aislamiento de adenovirus en muestras fecales en pacientes pediátricos con infección respiratoria aguda viral / Clinical significance of adenovirus isolation in feces of pediatric patients with viral acute respiratory infection

Introducción: En los pacientes con infección respiratoria aguda por adenovirus, el progreso de deglución de las secreciones determina el paso de los virus al tracto intestinal (heces). Objetivo: Estudiar el significado clínico del aislamiento de adenovirus en las heces de 348 pacientes con infección respiratoria causada por adenovirus. Métodos: Las Muestras respiratorias y heces fueron sembradas en la línea celular Hep-2 y las monocapas reveladas con anticuerpos monoclonales frente a los adenovirus. Resultados : en 62 pacientes (17,8%) se aislaron adenovirus. En 26 (41,9%) se aislaron simultáneamente en la muestra respiratoria y fecal, en 22 (35,4%) sólo en la muestra respiratoria y en 14 (22,5%) sólo en la muestra fecal. Globalmente los adenovirus fueron aislados en 48 muestras respiratorias (77,4%) y 40 heces (64,5%). En 3 casos la muestra fecal aglutinó frente a los adenovirus entéricos (serotipos 40 y 41). Conclusiones: El aislamiento de adenovirus en las heces de pacientes con infección respiratoria aguda puede ser un método útil y eficaz como apoyo al aislamiento en las muestras respiratorias (AU)

Introduction: In the patients with acute respiratory infections caused by adenovirus, the deglution process of respiratory secretions allows the presence of these viruses in the intestinal tract (feces). Aim: to study the clinical significance of adenovirus isolation in the feces of 348 patients with respiratory tract infection caused by adenovirus. Method: The respiratory and fecal samples were inoculated in the Hep-2 cell line and the monlayers stained by a monoclonal antibody against adenovirus. Results. Adenovirus were isolated simultaneously in the respiratory and fecal samples, in 22 (35,4%) only in the respiratory samples and in 14 (22,5%) only in the feces. Overall adenovirus were isolated in 48 respiratory samples (77,4%) and 40 feces (64,5%). In 3 patients the feces agglutinated with the enteric adenoviruses (serotypes 40 y 41). Conclusions: the isolation of adenovirus in the feces of patients with acute respiratory tract infection could be an efficient method to support the isolation in the respiratory samples (AU)

Características clínicas y epidemiológicas de los pacientes pediátricos con neumonía causada por los virus gripales / Clinical and epidemiological characteristics of the pediatric patients with influenza virus-induced pneumonia

Estudio retrospectivo sobre características clínicas y epidemiológicas de los pacientes pediátricos con neumonía y aislamiento de virus gripales (influenza A y B) durante el período 1995-2005. A las muestras respiratorias se les realizó la detección antigénica frente a los virus gripales y el aislamiento viral en cultivo celular. Durante el período de estudio se han diagnosticado 598 casos de infección respiratoria aguda causada por los virus gripales A y B, de los cuales 414 (69,2%) correspondían a pacientes pediátricos. Se diagnosticó neumonía gripal en 28 casos (6,7%). El virus gripal tipo A fue aislado en 22 casos (78,5%) y el virus gripal tipo B en 6 casos (21,5%). Los 22 virus gripales A fueron subtipados como pertenecientes 17 al subtipo H3 (77,2%) y 5 al subtipo H1 (22,8%). Las principales manifestaciones clínicas fueron: fiebre (96,4%), tos (78,5%), rinorrea (28,5%), cefalea (28,5%), otitis media aguada (14,2%) y mialgias, diarrea y conjuntivitis (3,5%). La edad media de nuestros pacientes fue de 4,4 años. El 75% de los pacientes precisó del ingreso hospitalario debido a su corta edad o complicaciones patológicas. En los pacientes ingresados se observó una estancia media de 8,3 días (intervalo de 3-17 días). Las manifestaciones clínicas son muy similares a las observadas en el resto de infecciones respiratorias agudas, precisando el estudio virológico para establecer su etiología definitiva (AU)

We performed a retrospective study of the clinical and epidemiological characteristics of pediatric patients with pneumonia and isolation of influenza viruses A and B during the 1995-2005 period. The specific antigenic detection and viral isolation in cell culture were the methods used in the etiological diagnosis. In the study period we detected 598 cases of acute respiratory infection caused by influenza ciruses A and B; of them 414 (69.2%) in pediatric patients. We could diagnosticated 28 patients (6.7%) with influenza pneumonia. Influenza A virus was isolated in 22 (78.5%) patients and Influenza B virus in 6 (21.5%) patients. The 22 influenza A viruses were subtyped as 17 (77,2%) H3 and 5 (22,8%) H1 subtypes. The most frequent clinical manifestations detected in the patients with pneumonia were: fever (96.4%), cough (78.5%), rhinorrea (28.5%), headache (28.5%), acute otitis (14,2%) and mialgia, diarrhea and conjunctivitis (3.5%). The mean age of patients was 4.4 years old; 75% of patients were hospitalized with a media of 8.3 days (3-17 days). The clinical manifestations of this pathology were very similar to detected in other acute viral respiratory infections, so only the virological methods could established the definitive etiological diagnosis (AU)

Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.

We studied the mechanisms and dynamics of the development of resistance to ceftazidime (CAZ) alone or combined with tobramycin (TOB) or ciprofloxacin (CIP) in vitro and in vivo (using a mouse model of lung infection with human antibiotic regimens). Pseudomonas aeruginosa strain PAO1 and its hypermutable derivative PAODeltamutS were used, and the results were compared with those previously obtained with CIP, TOB, and CIP plus TOB (CIP-TOB) under the same conditions. An important (200-fold) amplification of the number of resistant mutant cells was documented for PAODeltamutS-infected mice that were under CAZ treatment compared to the number for mice that received placebo, whereas the median number of resistant mutant cells was below the detection limits for mice infected by PAO1. These results were intermediate between the high amplification with CIP (50,000-fold) and the low amplification with TOB (10-fold). All CAZ-resistant single mutant cells selected in vitro or in vivo hyperproduced AmpC. On the other hand, the three combinations studied were found to be highly effective in the prevention of in vivo resistance development in mice infected with PAODeltamutS, although the highest therapeutic efficacy (in terms of mortality and total bacterial load reduction) compared to those of the individual regimens was obtained with CIP-TOB and the lowest was with CAZ-CIP. Nevertheless, mutant cells that were resistant to the three combinations tested were readily selected in vitro for PAODeltamutS (mutation rates from 1.2 x 10(-9) to 5.8 x 10(-11)) but not for PAO1, highlighting the potential risk for antimicrobial resistance development associated with the presence of hypermutable strains, even when combined therapy was used. All five independent CAZ-TOB-resistant PAODeltamutS double mutants studied presented the same resistance mechanism (AmpC hyperproduction plus an aminoglycoside resistance mechanism not related to MexXY), whereas four different combinations of resistance mechanisms were documented for the five CAZ-CIP-resistant double mutants.